Yasuo Ejima

2.3k citations
49 papers · 1.3k indexed · h-index 20

Yasuo Ejima

47 papers receiving 1.3k citations

Peers

Yasuo Ejima
Comparison fields: 5 of 98
  • Hepatology 225
  • Otorhinolaryngology 105
  • Cancer Research 215
  • Oncology 379
  • Pulmonary and Respiratory Medicine 394
Replace Blair Marshall with:
Blair Marshall United States
Zihao Yu China
Shen Fu China
Edwin P. M. Jansen Netherlands
Chun‐Ming Huang Taiwan
Silvia Mezi Italy
Dawei Chen China
Kai Li China
Rosa Fonti Italy
Yasuo Ejima relative to Blair Marshall United States Blair Marshall's profile →
Citations per field
00.5×4.2×
Blair Marshall · 1×
Citations per year

Countries citing papers authored by Yasuo Ejima

Since Specialization
Citations

This map shows the geographic impact of Yasuo Ejima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Ejima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Ejima more than expected).

Fields of papers citing papers by Yasuo Ejima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Ejima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Ejima. The network helps show where Yasuo Ejima may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yasuo Ejima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yasuo Ejima Line = papers co-authored together Yasuo Ejima links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202013
3 20194
4 201919
5 20178
6 201622
7 201626
8 20155
9 201524
10 20141
11 201423
12 201418
13 20126
14 201134
15 20112
16 20063
17 200556
18 200423
19 20022
20 200132

About Yasuo Ejima

Yasuo Ejima is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Radiation, Oncology and Genetics, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (10 papers), Effects of Radiation Exposure (7 papers), Lung Cancer Treatments and Mutations (7 papers), Glioma Diagnosis and Treatment (6 papers), Advanced Radiotherapy Techniques (6 papers), Lymphoma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Hepatology (225 citations), Otorhinolaryngology (105 citations), Cancer Research (215 citations), Oncology (379 citations) and Pulmonary and Respiratory Medicine (394 citations). Yasuo Ejima has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Ryohei Sasaki, Yoshiaki Sato, Masahide Shima, Yukio Kato, Keisuke Nakata, Shigenobu Nagataki, Toshinori Soejima, Hideki Nishimura, Kazuro Sugimura and Kenji Yoshida. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Radiation Research, Radiotherapy and Oncology, Japanese Journal of Clinical Oncology and SpringerPlus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026